EXELON CORP — Director's Dealing 2020

Jan 22, 2020

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: EXELON CORP (EXC)
CIK: 0001109357
Period of Report: 2019-12-31

Reporting Person: Von Hoene William A. Jr. (Sr. Executive Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	173868	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Restricted Stock Unit Awards 2017	$0		Common Stock (10112)	10112	Direct
Restricted Stock Unit Awards 2018	$0		Common Stock (17856)	17856	Direct
Restricted Stock Unit Awards 2019	$0		Common Stock (20986)	20986	Direct
Deferred Compensation Equivalent Shares	$0		Common Stock (3517)	3517	Direct
NQ Stock Option (right to buy) 03/12/2012	$39.81		Common Stock (88000)	88000	Direct
NQ Stock Option (right to buy) 01/24/2011	$43.4		Common Stock (67000)	67000	Direct
NQ Stock Option (right to buy) 01/25/2010	$46.09		Common Stock (33000)	33000	Direct

Footnotes

F1: Balance includes 3,896 shares acquired through quarterly dividend reinvestment during 2019.

F2: Previously awarded restricted stock units (RSUs) granted pursuant to the Exelon Long Term Incentive Plan. RSUs are granted annually at the Compensation and Leadership Development committee's first meeting in January or February and vest in 1/3 increments on the date of the committee's first annual meeting in the first, second and third years after the award was granted. Award balances accrue addtional RSUs through quarterly dividend reinvestment that vest on the same schedule as the underlying award.

F3: Balance includes 301 shares acquired through quarterly dividend reinvestment during 2019.

F4: Balance includes 532 shares acquired through quarterly dividend reinvestment during 2019.

F5: Balance includes 625 shares acquired through quarterly dividend reinvestment during 2019.

F6: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the company for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions, company matching contributions and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate due to periodic changes in the fund composition.

F7: Balance includes 81 share equivalents accrued through quarterly dividend reinvestment during 2019.

F8: Non qualified employee stock options, awarded pursuant to the Exelon Long Term Incentive Plan. Options are fully vested and expire on the tenth anniversay of the grant date referenced in Column 1.